Lv710
3510 积分 2021-08-30 加入
Progress towards a clinically-successful ATR inhibitor for cancer therapy
8小时前
已完结
Physicochemical and Metabolic Optimization of NAMPT Inhibitors Enables Effective Antibody–Drug Conjugates for Liquid and Solid Tumors
8小时前
已完结
Challenges and approaches to the design of hydrophilic linkers for antibody-drug conjugates
9小时前
已完结
Abstract 1289: ASP2998, a TROP2-targeted immunostimulatory antibody drug conjugate (iADC) with dual payloads, demonstrates potent efficacy and a favorable safety profile in nonclinical models
11小时前
已完结
Triptolide-based cleavable antibody-drug conjugates for pancreatic cancer
1天前
已完结
Unlocking the potential of bispecific ADCs for targeted cancer therapy
2天前
已完结
Disulfide rebridging platforms for site-specific ADC conjugation
6天前
已完结
Recent advances in antibody–drug conjugates
7天前
已完结
Neutrophil Elastase-Responsive Linkers for Precision Antibody–Drug Conjugates
7天前
已完结
From Unmet Medical Need to Drug Candidate: A Translational Therapeutic Development Roadmap Illustrated by Dual-Payload Antibody–Drug Conjugates
8天前
已完结
皖公网安备34019202002308
